Association of tumor perivascular desmin expression with survival in patients with sunitinib-treated renal carcinoma.

被引：0
|
作者：
Bolling, Magnus Frodin
Sandstrom, Per
Mezheyeuski, Artur
Egevad, Lars
Ostman, Arne
机构：
[1] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden
[2] Karolinska Univ Hosp, Dept Oncol Pathol, Stockholm, Sweden
[3] Karolinska Inst, Stockholm, Sweden
[4] Karolinska Inst, Stockholm, Sweden
[5] Belarusian State Med Univ, Dept Pathol, Minsk, BELARUS
[6] Belarusian State Med Univ, Dept Pathol, Stockholm, Sweden
[7] Karolinska Univ Hosp, Dept Pathol, Stockholm, Sweden
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11097
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Evaluation of polymorphisms in angiogenesis-related genes as predictive and prognostic markers for sunitinib-treated metastatic renal cell carcinoma patients
    Dornbusch, Juana
    Walter, Martina
    Gottschalk, Andrea
    Obaje, Alice
    Junker, Kerstin
    Ohlmann, Carsten-Henning
    Meinhardt, Matthias
    Zacharis, Aristeidis
    Zastrow, Stefan
    Schoffer, Olaf
    Grimm, Marc-Oliver
    Klug, Stefanie J.
    Wirth, Manfred P.
    Fuessel, Susanne
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2016, 142 (06) : 1171 - 1182
  • [22] Efficacy and toxicity of sunitinib in renal insufficiency patients with metastatic renal cell carcinoma.
    Kim, Ki Hyang
    Rha, Sun Young
    Kim, Ho Young
    Kim, Hye Ryun
    Sun, Jong-Mu
    Lim, Ho Yeong
    Lee, Hyo Jin
    Lee, Suee
    Bae, Woo Kyun
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [23] Prognostic factors for survival in 1059 patients treated with sunitinib for metastatic renal cell carcinoma
    Motzer, R. J.
    Escudier, B.
    Bukowski, R.
    Rini, B. I.
    Hutson, T. E.
    Barrios, C. H.
    Lin, X.
    Fly, K.
    Matczak, E.
    Gore, M. E.
    BRITISH JOURNAL OF CANCER, 2013, 108 (12) : 2470 - 2477
  • [24] Prognostic factors for survival in 1059 patients treated with sunitinib for metastatic renal cell carcinoma
    R J Motzer
    B Escudier
    R Bukowski
    B I Rini
    T E Hutson
    C H Barrios
    X Lin
    K Fly
    E Matczak
    M E Gore
    British Journal of Cancer, 2013, 108 : 2470 - 2477
  • [25] Genome-wide association meta-analysis identifies novel variants that correlate with efficacy outcomes in sunitinib-treated patients with metastatic renal cell carcinoma
    Diekstra, M.
    Swen, J.
    van der Zanden, L.
    Vermeulen, S.
    Boven, E.
    Mathijssen, R. H.
    Oskarsdottir, A.
    Oosterwijk, E.
    Cambon-Thomsen, A.
    Castellano, D.
    Fritsch, A.
    Garcia-Donas, J.
    Rodriguez-Antona, C.
    Jaehde, U.
    Rafnar, T.
    Stefansson, K.
    Bohringer, S.
    Kubo, M.
    Kiemeney, L.
    Guchelaar, H-J.
    ANNALS OF ONCOLOGY, 2021, 32 : S703 - S704
  • [26] The Impact of Tumor Burden Characteristics in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib
    Basappa, Naveen S.
    Elson, Paul
    Golshayan, Ali-Reza
    Wood, Laura
    Garcia, Jorge A.
    Dreicer, Robert
    Rini, Brian I.
    CANCER, 2011, 117 (06) : 1183 - 1189
  • [27] PROSPECTIVE CLINICAL TRIAL OF PREOPERATIVE SUNITINIB IN PATIENTS WITH RENAL CELL CARCINOMA.
    Hellenthal, Nicholas
    Underwood, Willie
    Penetrante, Remedios
    Litwin, Alan
    Zhang, Shaozeng
    Teh, Bin
    Kim, Hyung
    JOURNAL OF UROLOGY, 2010, 183 (04): : E569 - E569
  • [28] Body composition as a predictor of sunitinib toxicity in patients with renal cell carcinoma.
    Cushen, Samantha
    Ryan, Aoife M.
    Teo, MinYuen
    MacEneaney, Peter
    McLaughlin, Patrick
    Fitzpatrick, Frances
    Rozumna-Martynyuk, Nataliya
    McDermott, Raymond S.
    Power, Derek Gerard
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [29] Association of hyperbilirubinemia in pazopanib- or sunitinib-treated patients in COMPARZ with UGT1A1 polymorphisms
    Johnson, Toby
    Xu, Chun-fang
    Choueiri, Toni K.
    Deen, Keith C.
    Xue, Zhengyu
    Bartlett-Pandite, Arundathy N.
    Carpenter, Christopher
    Motzer, Robert John
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [30] Survival outcomes associated with different sunitinib dosing regimens in metastatic renal cell carcinoma.
    Cheng, Winnie
    Kletas, Victoria
    De Lemos, Mario Law
    Man, Sally
    Kollmannsberger, Christian K.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
12345